Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$30,000.00
Oct 1, 2025
Individual or sole proprietorship
PRIZE - Project Grant - PA: Maud Menten - Biomedical Research
187562
IG Strategic Research Priorities
• Strengthening the IG Research Community
• Addressing Health & Health System Priorities:
o Computational and Systems Biology
o From Models and Mechanisms to Therapies
o Health Services, Policy & Ethical, Legal and Social Issues Research
• Fostering Innovation, Commercialization & Translation Through Partnerships
$558,283.00
Oct 23, 2023
Not-for-profit organization or charity
Anti-Oppressive Tools and Practices to Strengthen the GBV Sector
GV230274
To do so, the project will (1) develop, implement, evaluate and optimize an anti-oppressive framework based on a Critical Discourse Analysis of resources most commonly used by GBV service providers; and (2) implement and evaluate the practices of trauma-informed yoga, nature-based healing and art therapy as culturally sensitive and anti-oppressive alternative approaches to healing.
$50,000.00
Mar 18, 2019
Not-for-profit organization or charity
Leading the way - Development and implementation of a knowledge transfer plan for the workers of CALACS (center for assistance and the fight against sexual assault)
ON18680
The organization will conceptualize new integration and training tools to take into account the impacts of the COVID-19 pandemic and equip workers who are members of the network committee with an intersectional feminist approach on the use of feminist sandplay therapy adapted to the needs of Francophone survivors of sexual and spousal violence.
$25,000.00
Jun 14, 2017
Improving Cell Encapsulation by Detection and Mitigation of Protruding Cells
EGP
$25,000.00
Mar 7, 2018
From trees to treatments. Catalytic amination of terpenes and biological screening
EGP
$39,188.09
Mar 4, 2025
For-profit organization
Sustainable crop protection and carbon sequestration in agricultural soil
1029602
Reazent's biological platform is based on enhanced metabolic flux in beneficial microbes by activating genes that have important functions. Reazent utilizes this expertise to offer effective and superior solutions to a wide range of applications.
$126,500.00
Mar 25, 2020
Academia
AI FOR DRUG DESIGN – DEVELOPMENT AND TESTING OF AI METHODS AND MOLECULE PARAMETERIZATION
947434
Successful discovery of a medicine for a target (gene/protein/pathway) usually last for many years and costs a private pharmaceutical organization billions of dollars, which in turn determines the unaffordable price of medicines in the Canadian and global markets.
$156,750.00
Mar 25, 2020
Academia
AI for drug design – development and testing of ai methods and molecule parameterization
947434
Successful discovery of a medicine for a target (gene/protein/pathway) usually last for many years and costs a private pharmaceutical organization billions of dollars, which in turn determines the unaffordable price of medicines in the Canadian and global markets.
$170,000.00
May 10, 2017
Novel roles of C1q tumor necrosis factor-related proteins (CTRPs) in relaxin receptor biology
RGPIN
$26,000.00
May 10, 2017
MT1-MMP regulation of matrix degradation and cell movement.
RGPIN